Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis
Daria Briukhovetska, Javier Suárez-Gosálvez, Cornelia Voigt, et al.
Immunity (2023) Vol. 56, Iss. 1, pp. 143-161.e11
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system
Martyna Strzelec, Jan Detka, Patrycja Mieszczak, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 78
Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death
Zhenlong Li, Rui Ma, Hejun Tang, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 624-641.e23
Closed Access | Times Cited: 28
Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling
Yanfen Cheng, Xuemei Zhong, Xin Nie, et al.
Phytomedicine (2023) Vol. 114, pp. 154757-154757
Closed Access | Times Cited: 33
Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy
David Andreu-Sanz, Sebastian Kobold
Cancers (2023) Vol. 15, Iss. 6, pp. 1650-1650
Open Access | Times Cited: 29
Preclinical application of a CD155 targeting chimeric antigen receptor T cell therapy for digestive system cancers
Kai Zhang, Yang Mi, Bohao Zhang, et al.
Oncogene (2025)
Closed Access | Times Cited: 1
NETosis: Sculpting tumor metastasis and immunotherapy
Yanyan Hu, Houhong Wang, Yang Liu
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 263-279
Open Access | Times Cited: 17
IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via STAT3/CD155 signaling axis
Junzhang Chen, Shiran Sun, Hui Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (Review)
Yuhang Zhou, Wenjie Han, Yun Feng, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 1
Open Access | Times Cited: 6
Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
Marjan Anvar, Kimiya Rashidan, Nima Arsam, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
CD155 and its receptors in cancer immune escape and immunotherapy
Ruijia Zhou, Shiyin Chen, Qiwen Wu, et al.
Cancer Letters (2023) Vol. 573, pp. 216381-216381
Closed Access | Times Cited: 16
Selective targeting of IL2Rβγ combined with radiotherapy triggers CD8- and NK-mediated immunity, abrogating metastasis in HNSCC
Jacob Gadwa, Maria Amann, Thomas E. Bickett, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 8, pp. 101150-101150
Open Access | Times Cited: 13
IL-22 in Atopic Dermatitis
Julia Laska, Maciej Tota, Julia Łacwik, et al.
Cells (2024) Vol. 13, Iss. 16, pp. 1398-1398
Open Access | Times Cited: 5
Tumor Microenvironment: Nurturing Cancer Cells for Immunoevasion and Druggable Vulnerabilities for Cancer Immunotherapy
Hongyang Yu, Jinyang Li, Shiyin Peng, et al.
Cancer Letters (2024) Vol. 611, pp. 217385-217385
Closed Access | Times Cited: 5
SLC7A8 overexpression inhibits the growth and metastasis of lung adenocarcinoma and is correlated with a dismal prognosis
Fang‐Ming Wang, Liqiang Xu, Zhongchao Zhang, et al.
Aging (2024) Vol. 16, Iss. 2, pp. 1605-1619
Open Access | Times Cited: 4
IL-22, a vital cytokine in autoimmune diseases
Jiajin Li, Zhen Wu, Yuxin Wu, et al.
Clinical & Experimental Immunology (2024) Vol. 218, Iss. 3, pp. 242-263
Open Access | Times Cited: 4
Guardians and Mediators of Metastasis: Exploring T Lymphocytes, Myeloid-Derived Suppressor Cells, and Tumor-Associated Macrophages in the Breast Cancer Microenvironment
Maria Rosaria Ruocco, Armando Gisonna, Vittoria Acampora, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6224-6224
Open Access | Times Cited: 4
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells
Luciana Melo Garcia, Achintyan Gangadharan, Pinaki P. Banerjee, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115122-115122
Open Access
Spatial-Omics Methods and Applications
Arutha Kulasinghe, Naomi Berrell, Meg L. Donovan, et al.
Methods in molecular biology (2025), pp. 101-146
Closed Access
Helper ILCs in the human hematopoietic system
Xiaoyu Su, Zhaoqun Deng, Yu Lan, et al.
Trends in Immunology (2025)
Closed Access
New insights into cancer immune checkpoints landscape from single-cell RNA sequencing
Qian Wang, Jiahui He, Tianyu Lei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 3, pp. 189298-189298
Closed Access
Modulation of Immune Cell Functions by CD226 Family Receptors
Ludovic Martinet
Elsevier eBooks (2025)
Closed Access
CD226 maintains regulatory T cell phenotype stability and metabolism by the mTOR/Myc pathway under inflammatory conditions
Jingchang Ma, Wei Hu, Yitian Liu, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113306-113306
Open Access | Times Cited: 10
CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis
Tao Zhang, Ramez Wahib, Dimitra E. Zazara, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Review of pre-metastatic niches in lung metastasis: From cells to molecules, from mechanism to clinics
Hongting Xie, Quan Sun, Xuelei Chu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189081-189081
Open Access | Times Cited: 3
RAC1high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis
Xiaoli Shi, Wei‐Wen Chen, Yefeng Yin, et al.
Cancer Letters (2024) Vol. 592, pp. 216909-216909
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top